IntraBio (@IntraBio) header
IntraBio (@IntraBio) profile picture

IntraBio

@IntraBio

IntraBio is a late-stage biopharmaceutical company developing novel therapies for rare (“orphan”) and common neurodegenerative diseases

 Oxford, England
intrabio.com
Joined November 2018
  • Tweets31
  • Following11
  • Followers91
Include

Only show posts containing:

Exclude

Hide posts containing:

Time range
-
Minimum likes
IntraBio has been dedicated to bringing novel treatments to patients with extremely high unmet medical needs like NPC, and today we celebrate a major milestone in this tremendous effort businesswire.com/news/home/2…
IntraBio Announces U.S. FDA Approval of AQNEURSA for the Treatment of Niemann-Pick Disease Type C

IntraBio Announces U.S. FDA Approval of AQNEURSA for the Treatment of Niemann-Pick Disease Type C

IntraBio Inc., a leader in the discovery and development of innovative drugs for rare neurodegenerative diseases, today announced that the U.S. Food and Drug...

businesswire.com
2
379
IntraBio Reports Positive Data from IB1001 Multinational Clinical Trial for the Treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease) accesswire.com/660477/IntraB…
1
IntraBio Appoints Jim Meyers as President and CEO accesswire.com/618176/IntraB…
1
Professor Michael Strupp Receives the 2020 Galenus-von-Pergamon Award accesswire.com/viewarticle.a…
IntraBio Reports Further Detail on Positive Data from IB1001 Multinational Clinical Trial for the Treatment of Niemann-Pick disease Type C accesswire.com/viewarticle.a…
New hope for Treatment Against Niemann-Pick disease Type C businessnewstribune.com/2020… via @Business News Tribune
"IntraBio Reports Positive Data from NPC Study" - @GlobalGenes globalgenes.org/2020/10/06/i…
IntraBio Reports Positive Data from IB1001 Multinational Clinical Trial for the Treatment of Niemann-Pick disease Type C accesswire.com/viewarticle.a…
1
IntraBio retweeted
NNPDF (@nnpdf) profile picture
NNPDF@nnpdf24 Apr 2019
JOIN US THIS MORNING for the NNPDF Industry webinar series as @IntraBio presents at 11:00 am ET/8:00 am PT. Hear updates regarding their Clinical Trial IB1001-201 and more! REGISTER NOW at: bit.ly/2KYdOvD #NPC #niemannpick #nnpdf
Image from NNPDF (@nnpdf)
1
2
Load more